Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael J. Dauphinée is active.

Publication


Featured researches published by Michael J. Dauphinée.


Cellular Immunology | 1983

Deficient T-cell mitogen response in murine experimental autoimmune myasthenia gravis: A defect in the adherent cell population

Premkumar Christadoss; Michael J. Dauphinée; Jon Lindstrom; Howard Dang; Gabriel Fernandes; Norman Talal

T-Lymphocyte number and functions are often reduced, while B-lymphocyte function is often increased in patients with autoimmune disorders. To study the mechanisms responsible for these T-cell malfunctions in autoimmunity we adapted the murine experimental autoimmune myasthenia gravis (EAMG) model. Splenocytes from C57BL/6 mice immunized with acetylcholine receptors (AChR) in complete Freunds adjuvant (CFA) produced approximately half the amount of concanavalin A (Con A)-induced interleukin 2 (IL-2) as did splenocytes of CFA-inoculated controls. Further, AChR plus CFA-immunized splenocytes showed a marked reduction in T-cell proliferative responses induced by Con A or phytohemagglutinin when compared with CFA-inoculated controls. By contrast, lipopolysaccharide-induced B-cell function is preserved. Deficient Con A splenic T-cell response is seen early after secondary inoculation with CFA or AChR in CFA. T-Cell recovery occurs in CFA-inoculated mice but not in AChR plus CFA-inoculated mice. Defective Con A splenic T-cell response seen early after secondary immunization with CFA or AChR in CFA is due to the presence of a defective splenic adherent cell population. Moreover, defective Con A splenic T-cell response seen after established autoimmunity to AChR in EAMG is also due to the presence of a defective splenic adherent cell population.


Journal of Autoimmunity | 1989

Characterization of the IL-2-receptor on rheumatoid arthritis synovial fluid T cells

Michael J. Dauphinée; Howard Dang; Eliezer Flescher; Katharine Wilson-Burris; Dionicio Galarza; Karl Hempel; Norman Talal

We studied the hypoproliferative response of synovial fluid (SF) T cells in rheumatoid arthritis (RA) using a mitogenic monoclonal antibody (MoAb) specific for the T-cell antigen receptor-associated CD3 complex. RASF T cells are defective in their proliferative response and in the induction of the Tac (p55) component of the IL-2-receptor (IL-2-R) when stimulated with anti-CD3 monoclonal antibody (MoAb). However, fresh RASF T cells bear demonstrable IL-2-R in cross-linking experiments which are not seen in unstimulated peripheral blood (PB). These receptors are functional since RASF T cells proliferate in response to recombinant IL-2 (rIL-2) better than fresh PB T cells from either normal or RA patients. Scatchard analysis indicates increased (4-fold) numbers of high affinity IL-2-R on (phytohaemagglutinin) PHA-activated RASF T cells as compared with comparably activated RAPB T cells. Phorbol myristate acetate (PMA) induces Tac antigen expression in RASF but does not lead to proliferation. The hyporesponsiveness of RASF T cells does not appear to result from lack of IL-2-R, lack of IL-2-R inducibility, or proliferative potential.


Arthritis & Rheumatism | 1990

Detection of serum antibodies to retroviral proteins in patients with primary Sjögren's syndrome (autoimmune exocrinopathy)

Norman Talal; Michael J. Dauphinée; Howard Dang; Steve S. Alexander; Darrenn J. Hart; Robert F. Garry


Arthritis & Rheumatism | 1981

Treatment of NZB/NZW F1 hybrid mice with Mycobacterium bovis strain BCG or type II interferon preparations accelerates autoimmune disease.

Edgar G. Engleman; Gerald Sonnenfeld; Michael J. Dauphinée; John S. Greenspan; Norman Talal; Hugh O. McDevitt; Thomas C. Merigan


Proceedings of the National Academy of Sciences of the United States of America | 1974

Thymosin Corrects the Abnormal DNA Synthetic Response of NZB Mouse Thymocytes

Michael J. Dauphinée; Norman Talal; Allan L. Goldstein; Abraham White


Journal of Immunology | 1975

Reversible Restoration by Thymosin of Antigen-Induced Depression of Spleen DNA Synthesis in NZB Mice

Michael J. Dauphinée; Norman Talal


Journal of Immunology | 1974

Generation of Non-Complement-Fixing, Blocking Factors by Lysosomal Extract Treatment of Cytotoxic Anti-Tumor Antibodies

Michael J. Dauphinée; Norman Talal; Isaac P. Witz


Journal of Immunology | 1979

Failure of NZB Spleen to Respond to Prethymic Bone Marrow Suppressor Cells

Michael J. Dauphinée; Norman Talal


Journal of Immunology | 1975

Evidence for an Abnormal Microenvironment in the Thymus of New Zealand Black Mice

Michael J. Dauphinée; Donald W. Palmer; Norman Talal


Proceedings of the National Academy of Sciences of the United States of America | 1973

Alteration in DNA synthetic response of thymocytes from NZB mice of different ages.

Michael J. Dauphinée; Norman Talal

Collaboration


Dive into the Michael J. Dauphinée's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Howard Dang

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Premkumar Christadoss

University of Texas Medical Branch

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Allan L. Goldstein

George Washington University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Dionicio Galarza

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Eliezer Flescher

University of Texas Health Science Center at San Antonio

View shared research outputs
Top Co-Authors

Avatar

Gabriel Fernandes

United States Department of Veterans Affairs

View shared research outputs
Researchain Logo
Decentralizing Knowledge